Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Inflammatory Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025
Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound Viremia.
Journal: The Journal of infectious diseases
Published: December 21, 2024
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.
Journal: AIDS (London, England)
Published: January 25, 2023
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
Journal: PLoS pathogens
Published: January 11, 2023
Pre-clerkship Teaching and Learning in the Virtual Learning Environment: Lessons Learned and Future Directions.
Journal: Medical science educator
Published: November 12, 2022
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Journal: Nature communications
Published: June 13, 2021
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2021
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Journal: Cell reports
Published: March 04, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Journal: Science advances
Published: March 02, 2021
Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 03, 2020
Last Updated: 09/26/2026